Peteranderl Christin, Sznajder Jacob I, Herold Susanne, Lecuona Emilia
Department of Internal Medicine II, University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany.
Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Front Immunol. 2017 Apr 18;8:446. doi: 10.3389/fimmu.2017.00446. eCollection 2017.
The respiratory epithelium is lined by a tightly balanced fluid layer that allows normal O and CO exchange and maintains surface tension and host defense. To maintain alveolar fluid homeostasis, both the integrity of the alveolar-capillary barrier and the expression of epithelial ion channels and pumps are necessary to establish a vectorial ion gradient. However, during pulmonary infection, auto- and/or paracrine-acting mediators induce pathophysiological changes of the alveolar-capillary barrier, altered expression of epithelial Na,K-ATPase and of epithelial ion channels including epithelial sodium channel and cystic fibrosis membrane conductance regulator, leading to the accumulation of edema and impaired alveolar fluid clearance. These mediators include classical pro-inflammatory cytokines such as TGF-β, TNF-α, interferons, or IL-1β that are released upon bacterial challenge with , or as well as in viral infection with influenza A virus, pathogenic coronaviruses, or respiratory syncytial virus. Moreover, the pro-apoptotic mediator TNF-related apoptosis-inducing ligand, extracellular nucleotides, or reactive oxygen species impair epithelial ion channel expression and function. Interestingly, during bacterial infection, alterations of ion transport function may serve as an additional feedback loop on the respiratory inflammatory profile, further aggravating disease progression. These changes lead to edema formation and impair edema clearance which results in suboptimal gas exchange causing hypoxemia and hypercapnia. Recent preclinical studies suggest that modulation of the alveolar-capillary fluid homeostasis could represent novel therapeutic approaches to improve outcomes in infection-induced lung injury.
呼吸道上皮由一层平衡紧密的液体层覆盖,该液体层允许氧气和二氧化碳正常交换,并维持表面张力和宿主防御功能。为维持肺泡液体稳态,肺泡-毛细血管屏障的完整性以及上皮离子通道和泵的表达对于建立矢量离子梯度都是必要的。然而,在肺部感染期间,自分泌和/或旁分泌作用的介质会引起肺泡-毛细血管屏障的病理生理变化,上皮钠钾ATP酶以及包括上皮钠通道和囊性纤维化跨膜传导调节因子在内的上皮离子通道的表达改变,导致水肿积聚和肺泡液体清除受损。这些介质包括经典的促炎细胞因子,如转化生长因子-β、肿瘤坏死因子-α、干扰素或白细胞介素-1β,它们在受到细菌攻击(如肺炎链球菌或金黄色葡萄球菌)以及甲型流感病毒、致病性冠状病毒或呼吸道合胞病毒等病毒感染时释放。此外,促凋亡介质肿瘤坏死因子相关凋亡诱导配体、细胞外核苷酸或活性氧会损害上皮离子通道的表达和功能。有趣的是,在细菌感染期间,离子转运功能的改变可能作为对呼吸道炎症特征的额外反馈回路,进一步加重疾病进展。这些变化导致水肿形成并损害水肿清除,从而导致气体交换不佳,引起低氧血症和高碳酸血症。最近的临床前研究表明,调节肺泡-毛细血管液体稳态可能代表改善感染性肺损伤预后的新治疗方法。